ORI-15412

N/A

Report date: 2025/07/09 16:56:39
NME

Base Information

Drug NameORI-15412
Drug Alias NameORI-15412
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsTriple Negative Breast NeoplasmsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrigenis GmbH
China Registration ClassN/A

Develop Information

Active CompaniesOrigenis GmbH
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast NeoplasmsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A